NCT07405099Enrolling by invitation
Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease
The Analysis of End-stage Renal Disease for Outcomes in Pancreatic Surgery
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
End-stage renal disease (ESRD) patients often present risk factors for many surgical complications. The severity of renal failure and whether the patient is receiving renal replacement therapy are also related to the difficulty of pancreatic and other major surgeries, causing many ESRD patients to hesitate when choosing surgery. Therefore, this project aims to retrospectively collect basic data, preoperative and postoperative blood tests (blood cell counts, biochemistry, tumor markers, glucose-related, lipid-related), and preoperative and postoperative imaging examinations (CT, MRI, Ultrasound, PET scan, Endoscopy, etc.) of ESRD patients who underwent pancreatic surgery at our hospital.the investigators aim to compare whether surgical methods, severity of renal failure, use of renal replacement therapy, and lesion margin clearance rates affect the occurrence of surgical complications, length of hospital stay, length of ICU stay, re-operation rates or severe complications, medical costs, and related quality of life. This analysis is intended to understand and analyze the surgical prognosis, care priorities, common complications, and the management and outcomes of our team for ESRD patients undergoing pancreatic surgery, with the expectation of providing more diverse and specific treatment recommendations for these patients in the future.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 4 Feb 2026
- Start date
- Jan 2016
- Primary completion date
- Dec 2034
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Chronic kidney disease, Pancreatic cancer
- NCT number
- NCT07405099
What you commit to
- Study type: Observational
- Planned participants: 100
- From Jan 2016 to the primary completion date, Dec 2034
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of other active malignancies prior to diagnosis.
Other illness
- Minors, pregnant women, breastfeeding women, and patients with psychiatric disorders.
Age
- Patients under 20 or over 75 years of age at this hospital.
Who the study is looking for
- Males or females aged between 20 and 75 years.
- Patients scheduled to undergo pancreatic surgery.
Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.